Abstract
Benign prostatic hyperplasia (BPH) is recognized as the common chronic disease that affect majority of men in their elder ages. Nevertheless, there are no effective documents for BPH treatment. Even though great progression has been made on BPH by laser surgery, it also faces several challenges. In this study, our aims were to explore the effects of 1470-nm laser vaporization on BPH. For the research, a total of 170 BPH patients were enrolled. A 1470-nm laser vaporization apparatus was purchased for the surgery. The indicators such as serum sodium, international prostate symptom score (IPSS), Quality of life (QOL), maximum flow rate (Qmax), prostate specific antigen (PSA), and average Post-void Residual Volume (PVR) were detected for evaluating the prostate function. The operation was successful in all 170 patients, neither of whom converted to transurethral resection of the prostate (TURP) nor to open surgery. The surgery time was 52.3 ± 5.6 min, the laser emission time was 35.6 ± 3.2 min, the energy consumption was 254.1 ± 19.3 kJ. The level of serum sodium showed no significant difference between the pre- and post-operation. Qmax was significantly increased in post-operation, while IPSS, QOL, PVR, and PSA were significantly decreased in the post-operation. The 1470-nm laser vaporization treatment protected patients against BPH, indicating that 1470-nm laser vaporization might be important on treating BPH, which provided solid foundation for further clinical treatment.
Similar content being viewed by others
References
Kaplan SA (2016) Re: Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)-focus on the UK. J Urol 195:425–426
Speakman M, Kirby R, Doyle S, Ioannou C (2015) Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int 115:508–519
Chung KS, Shin SJ, Lee NY, Cheon SY, Park W, Sun SH et al (2016) Anti-proliferation effects of garlic (Allium Sativum L.) on the progression of benign prostatic hyperplasia. Phytother Res 30:1197–1203
Whitty JA, Crosland P, Hewson K, Narula R, Nathan TR, Campbell PA et al (2014) A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia. BJU Int 113(Suppl 2):21–28
Hueber PA, Bienz MN, Valdivieso R, Lavigueur-Blouin H, Misrai V, Rutman M et al (2015) Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 194:462–469
Large T, Borofsky MS, Lingeman JE (2016) Re: Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes and Re: GreenLight™ Laser (XPS) Photoselective Vapo-Enucleation versus Holmium Laser Enucleation of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia: A Randomized Controlled Study. J Urol 195:228–231
Elshal AM, Elkoushy MA, El-Nahas AR, Shoma AM, Nabeeh A, Carrier S, Elhilali MM (2015) GreenLight Laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol 193:927–934
Wezel F, Wendt-Nordahl G, Huck N, Bach T, Weiss C, Michel MS et al (2010) New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device. World J Urol 28:181–186
Seitz M, Reich O, Gratzke C, Schlenker B, Karl A, Bader M et al (2009) High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 24:172–178
Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C et al (2009) Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci 24:419–424
Amzayyb M, van den Bos RR, Kodach VM, de Bruin DM, Nijsten T, Neumann HA et al (2010) Carbonized blood deposited on fibres during 810, 940 and 1,470 nm endovenous laser ablation: thickness and absorption by optical coherence tomography. Lasers Med Sci 25:439–447
Yang KS, Seong YK, Kim IG, Han BH, Kong GS (2011) Initial experiences with a 980 nm diode laser for photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. Korean J Urol 52:752–756
Malik RD, Wang CE, Lapin B, Gerber GS, Helfand BT (2015) Comparison of patients undergoing laser vaporization of the prostate versus TURP using the ACS-NSQIP database. Prostate Cancer Prostatic Dis 18:18–24
Yee CH, Wong JH, Chiu PK, Teoh JY, Chan CK, Chan ES et al (2016) Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate. Urol Ann 8:458–463
Malek RS, Barrett DM, Kuntzman RS (1998) High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51:254–256
Bouchier Hayes DM, Van ASP, Crowe H, Challacombe B, Costello AJ (2010) A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 105:964–969
Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ (2006) KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 20:580–585
Rieken M, Ebinger Mundorff N, Bonkat G, Wyler S, Bachmann A (2010) Complications of laser prostatectomy: a review of recent data. World J Urol 28:53–62
Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C (2008) Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 71:247–251
Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W et al (2007) The diode laser: a novel side-firing approach for laser vaporisation of the human prostate—immediate efficacy and 1-year follow-up. Eur Urol 52:1717–1722
Wu G, Hong Z, Li C, Bian C, Huang S, Wu D (2016) A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up. Lasers Med Sci 31:599–604
Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:349–355
Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229–1233
Acknowledgements
Not applicable.
Funding
This study was provided by the Science and Technology development project of Taian in 2012 (NO. 20123024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the ethics committee of Qilu Hospital of Shandong University and Taian City Central Hospital.
Consent for publication
The study was undertaken with the patient’s consent.
Availability of data and material
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Liu, Z., Zhao, Y., Wang, X. et al. Critical reviews of 1470-nm laser vaporization on benign prostatic hyperplasia. Lasers Med Sci 33, 323–327 (2018). https://doi.org/10.1007/s10103-017-2377-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-017-2377-5